Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma patients after surgery.
https://www.foxnews.com/health/cancer-vaccine-prevents-deadly-melanoma-returning-spreading-landmark-trial
https://www.foxnews.com/health/cancer-vaccine-prevents-deadly-melanoma-returning-spreading-landmark-trial